Holen Sie sich die Stockscreener-App
41.72
0.17%
0.07
Handel nachbörslich:
41.72
Xoma Royalty Corp Aktie (XOMA) Neueste Nachrichten
[Form 4] XOMA Royalty Corp Insider Trading Activity - Stock Titan
Director at XOMA (XOMA) granted 3,586 RSUs vesting over 12 months - Stock Titan
Director at XOMA (NASDAQ: XOMA) granted 3,586 RSUs vesting over 12 months - Stock Titan
XOMA Royalty Corp (XOMA) director receives 3,586 RSU equity grant - Stock Titan
Equity grant: XOMA (XOMA) director awarded 3,586 RSUs of common stock - Stock Titan
XOMA Royalty (XOMA) merger: $39.00 cash + one CVR tied to Janssen litigation - Stock Titan
XOMA Royalty Corporation (Formerly XOMA Corp) Files Form 8-K Detailing Bylaws Amendments and Stock Awards – May 2026 - Minichart
XOMA Royalty shareholders approve incentive plan amendments and bylaw changes - Investing.com UK
XOMA (NASDAQ: XOMA) shareholders approve equity plans and new bylaw provisions - Stock Titan
XOMA ROYALTY CORPXOMA 8 3/8 PERP (XOMAO) Stock Price & Overview - ChartMill
XOMAO Stock Price and Chart — NASDAQ:XOMAO - TradingView
BVF group (NASDAQ: XOMA) converts 5,003 Series X preferred into common - Stock Titan
BVF group boosts XOMA (XOMA) ownership to 43.3% after Series X share conversion - Stock Titan
XOMA Royalty amends merger agreement with Ligand Pharmaceuticals By Investing.com - Investing.com Canada
Ligand Pharmaceuticals Files 8-K Announcing Amendment No. 1 to Agreement and Plan of Merger with XOMA Royalty Corporation 10 - Minichart
XOMA Royalty Corp Announces SEC Filing for Merger Agreement with Ligand Pharmaceuticals - Minichart
XOMA Royalty amends merger agreement with Ligand Pharmaceuticals - Investing.com
Ligand Pharmaceuticals amends merger agreement with XOMA Royalty Corporation - Investing.com
XOMA Royalty Amends Ligand Merger Agreement, Adding Holding Company to Advance Acquisition - TradingView
XOMA Royalty (XOMA) adds new holding company to structure of Ligand acquisition - Stock Titan
Ligand (NASDAQ: LGND) amends XOMA Royalty merger, adds Nevada holding company - Stock Titan
XOMA royalty (XOMA) price target decreased by 32.32% to 45.39 - MSN
Woodline (XOMA) reports 640,001-share, 5.4% passive stake in XOMA Royalty - Stock Titan
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Veris Residential, Inc. (NYSE – VRE), XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX) - GlobeNewswire Inc.
XOMA ROYALTY CORP (NASDAQ:XOMAP) Passes Navellier’s Little Book Growth Screen with Strong Momentum - ChartMill
Ligand-Xoma Deal Would Combine Two Royalty Aggregators -- WSJ - Moomoo
XOMA Stock Price, Quote & Chart | XOMA ROYALTY CORPORATION (NASDAQ:XOMA) - ChartMill
TradingKey - TradingKey
Q1 2026: XOMA (NASDAQ: XOMA) profit rises to $4.5M on royalty income - Stock Titan
XOMA Royalty Corporation (NASDAQ:XOMA) Checks Nearly Every Box in Louis Navellier’s Eight-Rule Growth Stock Screen - ChartMill
XOMA Royalty Corporation (NASDAQ:XOMA) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
XOMA Royalty CorporationDepositary Shares Rep Series B 8.375% Cumulative Preferred Stock - TradingView
Ligand set to report earnings as XOMA deal reshapes growth outlook - Investing.com
XOMA Royalty (XOMA) Projected to Post Earnings on Tuesday - MarketBeat
XOMA (XOMA) holders offered $39 cash plus CVRs in Ligand buyout - Stock Titan
Ligand Pharmaceuticals Launches Takeover Plan at XOMA Royalty Corporation with 47.0% Stake - TradingView
This Appian Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Thursday - Sahm
[SCHEDULE 13G] XOMA Royalty Corp Passive Investment Disclosure (>5%) - Stock Titan
Weekly Buzz: FDA Okays Saphnelo Pen, EC Clears Acromegaly Drug, SNGX Slumps, LGND Snaps Up XOMA - RTTNews
H.C. Wainwright cuts XOMA stock rating on Ligand acquisition By Investing.com - Investing.com Canada
H.C. Wainwright cuts XOMA stock rating on Ligand acquisition - Investing.com
BVF group backs XOMA Royalty Corp (XOMA) merger with 21.4% locked-up stake - Stock Titan
LGND: XOMA Buy Adds 100+ Assets - Yahoo Finance
XOMA Investors Have the Opportunity to Join Investigation of XOMA Royalty Corporation with the Schall Law Firm - GlobeNewswire
Ligand to acquire XOMA Royalty - The Pharma Letter
XOMA Royalty (XOMA) Moves 10.7% Higher: Will This Strength Last? - Yahoo Finance
Ligand Pharmaceuticals to Buy XOMA Royalty for $39/Share, Lifts 2026 Guidance and EPS Outlook - MarketBeat
BlackRock (NASDAQ: XOMA) reports 5.4% stake in XOMA Royalty Corp - Stock Titan
XOMA (XOMA) closes Generation Bio acquisition, details cash-plus-CVR terms and LNP assets - Stock Titan
Are OGN, RMAX, XOMA, REAX Obtaining Fair Deals for their Shareholders? - The Malaysian Reserve
HC Wainwright & Co. maintains XOMA Royalty (XOMA) buy recommendation - MSN
Promising Biotech Stocks To Watch TodayApril 27th - MarketBeat
Ligand Bets On Royalty Growth With XOMA Buyout Worth Over $700 Million - Benzinga
Ligand Is Buying Xoma Royalty For $739 Million In Cash - Finimize
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):